Persistent vascular dysfunction following an acute nonpharmacological reduction in blood pressure in hypertensive patients.

ABSTRACT

BACKGROUND: Vascular dysfunction, an independent risk factor for cardiovascular disease, often persists in patients with hypertension, despite improvements in blood pressure control induced by antihypertensive medications. METHODS: As some of these medications may directly affect vascular function, this study sought to comprehensively examine the impact of reducing blood pressure, by a nonpharmacological approach (5 days of sodium restriction), on vascular function in 22 hypertensive individuals (14 men/8 women, 50 ±â€Š10 years). Following a 2-week withdrawal of antihypertensive medications, two 5-day dietary phases, liberal sodium (liberal sodium, 200 mmol/day) followed by restricted sodium (restricted sodium, 10 mmol/day), were completed. Resting blood pressure was assessed and vascular function, at both the conduit and microvascular levels, was evaluated by brachial artery flow-mediated dilation (FMD), reactive hyperemia, progressive handgrip exercise, and passive leg movement (PLM). RESULTS: Despite a sodium restriction-induced fall in blood pressure (liberal sodium 141 ±â€Š14/85 ±â€Š9; restricted sodium 124 ±â€Š12/79 ±â€Š9 mmHg, P < 0.01 for both SBP and DBP), FMD (liberal sodium 4.6 ±â€Š1.8%; restricted sodium 5.1 ±â€Š2.1%, P = 0.27), and reactive hyperemia (liberal sodium 548 ±â€Š201; restricted sodium 615 ±â€Š206 ml, P = 0.08) were not altered. Similarly, brachial artery vasodilation during handgrip exercise was not different between conditions (liberal sodium Δ0.36 ±â€Š0.19 mm; restricted sodium Δ0.42 ±â€Š0.18 mm, P = 0.16). Lastly, PLM-induced changes in peak blood flow (liberal sodium 5.3 ±â€Š2.5; restricted sodium 5.8 ±â€Š3.6 ml/min per mmHg, P = 0.30) and the total vasodilatory response [liberal sodium 2 (0.9-2.5) vs. restricted sodium 1.7 (1.1-2.6) ml/min per mmHg; P = 0.5] were also not different between conditions. CONCLUSION: Thus vascular dysfunction, at both the conduit and microvascular levels, persists in patients with hypertension even when blood pressure is acutely reduced by a nonpharmacological approach.